MYC directly transactivates CR2/CD21, the receptor of the Epstein–Barr virus, enhancing the viral infection of Burkitt lymphoma cells

1. Molina, E.
2. García-Gutiérrez, L.
3. Junco, V.
4. Perez-Olivares, M.
5. de Yébenes, V.G.
6. Blanco, R.
7. Quevedo, L.
8. Acosta, J.C.
9. Marín, A.V.
10. Ulgiati, D.
11. Merino, R.
12. Delgado, M.D.
13. Varela, I.
14. Regueiro, J.R.
15. Moreno de Alborán, I.
16. Ramiro, A.R.
17. León, J.